Cognitive impairment among medicare home health patients: comparing available measures.
Cognitive impairment among medicare home health patients: comparing available measures.
复制标题
DOI：
10.1080/01621424.2021.2009392
复制
发表时间：
2022-04
影响因子：
1.4
通讯作者：
中科院分区：
文献类型：
--
作者：
有越来越多的兴趣了解家庭健康利用和结果的认知障碍（CI）。然而，不同研究中测量家庭健康期间CI的方法差异很大，对研究结果的潜在影响知之甚少。在接受家庭健康的社区生活医疗保险受益人的全国代表性样本（2011-2016年）中，我们使用四种不同的测量方法比较了估计的CI患病率，并评估了特定测量方法的优势和局限性。CI患病率估计范围从18.4%的样本可能患有痴呆症，从国家调查数据;到27.8%的诊断为痴呆症，从医疗保险索赔;到26.7%的记忆缺陷和/或决策受损，以及43.9%的认知功能降低，从OASIS。研究人员必须慎重选择CI措施，并对其优点和局限性保持透明。无论采用何种方法，相当一部分家庭健康患者患有CI，这支持了在这一领域进行研究的重要性。
There is growing interest in understanding home health utilization and outcomes for those with cognitive impairment (CI). Yet, approaches to measuring CI during home health vary widely across studies, with little known regarding potential implications for findings. Among a nationally representative sample of community-living Medicare beneficiaries receiving home health (2011–2016), we compare estimated CI prevalence using four different measures and evaluate measure-specific strengths and limitations. CI prevalence estimates ranged from 18.4% of the sample with probable dementia from national survey data; to 27.8% with diagnosed dementia, from Medicare claims; to 26.7% with memory deficit and/or impaired decision-making and 43.9% with reduced cognitive function, from OASIS. Researchers must be deliberate in their choice of CI measure and transparent regarding its benefits and limitations. Regardless of the measure used, a sizable portion of the home health patients have CI, supporting the importance of ongoing research in this area.